These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14520743)

  • 1. Detection of ligands from a dynamic combinatorial library by X-ray crystallography.
    Congreve MS; Davis DJ; Devine L; Granata C; O'Reilly M; Wyatt PG; Jhoti H
    Angew Chem Int Ed Engl; 2003 Sep; 42(37):4479-82. PubMed ID: 14520743
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing performance of computational tools for combinatorial library design.
    Evensen E; Eksterowicz JE; Stanton RV; Oshiro C; Grootenhuis PD; Bradley EK
    J Med Chem; 2003 Nov; 46(24):5125-8. PubMed ID: 14613315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists.
    Bradley EK; Miller JL; Saiah E; Grootenhuis PD
    J Med Chem; 2003 Sep; 46(20):4360-4. PubMed ID: 13678414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of 3D-database molecular docking studies into homology models.
    Oshiro C; Bradley EK; Eksterowicz J; Evensen E; Lamb ML; Lanctot JK; Putta S; Stanton R; Grootenhuis PD
    J Med Chem; 2004 Jan; 47(3):764-7. PubMed ID: 14736258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation mining: an algorithm for finding biologically relevant conformations.
    Putta S; Landrum GA; Penzotti JE
    J Med Chem; 2005 May; 48(9):3313-8. PubMed ID: 15857136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure.
    Kawanishi N; Sugimoto T; Shibata J; Nakamura K; Masutani K; Ikuta M; Hirai H
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5122-6. PubMed ID: 16876403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
    Cancilla MT; He MM; Viswanathan N; Simmons RL; Taylor M; Fung AD; Cao K; Erlanson DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3978-81. PubMed ID: 18579375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitors.
    Aronov AM; Bemis GW
    Proteins; 2004 Oct; 57(1):36-50. PubMed ID: 15326593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based lead discovery using X-ray crystallography.
    Hartshorn MJ; Murray CW; Cleasby A; Frederickson M; Tickle IJ; Jhoti H
    J Med Chem; 2005 Jan; 48(2):403-13. PubMed ID: 15658854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodipyrazoles: a new class of potent CDK2 inhibitors.
    D'Alessio R; Bargiotti A; Metz S; Brasca MG; Cameron A; Ermoli A; Marsiglio A; Polucci P; Roletto F; Tibolla M; Vazquez ML; Vulpetti A; Pevarello P
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1315-9. PubMed ID: 15713378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SDOCKER: a method utilizing existing X-ray structures to improve docking accuracy.
    Wu G; Vieth M
    J Med Chem; 2004 Jun; 47(12):3142-8. PubMed ID: 15163194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.
    Al-awar RS; Ray JE; Hecker KA; Joseph S; Huang J; Shih C; Brooks HB; Spencer CD; Watkins SA; Schultz RM; Considine EL; Faul MM; Sullivan KA; Kolis SP; Carr MA; Zhang F
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3925-8. PubMed ID: 15225699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysis.
    Tang J; Shewchuk LM; Sato H; Hasegawa M; Washio Y; Nishigaki N
    Bioorg Med Chem Lett; 2003 Sep; 13(18):2985-8. PubMed ID: 12941317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular approaches to generate libraries of chelating bidentate ligands for homogeneous catalysis.
    Breit B
    Angew Chem Int Ed Engl; 2005 Oct; 44(42):6816-25. PubMed ID: 16217817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling structure-based design with combinatorial chemistry: application of active site derived pharmacophores with informative library design.
    Eksterowicz JE; Evensen E; Lemmen C; Brady GP; Lanctot JK; Bradley EK; Saiah E; Robinson LA; Grootenhuis PD; Blaney JM
    J Mol Graph Model; 2002 Jun; 20(6):469-77. PubMed ID: 12071281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General model for estimation of the inhibition of protein kinases using Monte Carlo simulations.
    Tominaga Y; Jorgensen WL
    J Med Chem; 2004 May; 47(10):2534-49. PubMed ID: 15115396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles.
    Wood ER; Kuyper L; Petrov KG; Hunter RN; Harris PA; Lackey K
    Bioorg Med Chem Lett; 2004 Feb; 14(4):953-7. PubMed ID: 15013000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD; Corbett AD; Gleason JL; Kazlauskas RJ
    Chemistry; 2005 Mar; 11(6):1708-16. PubMed ID: 15565741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II.
    Mocharla VP; Colasson B; Lee LV; Röper S; Sharpless KB; Wong CH; Kolb HC
    Angew Chem Int Ed Engl; 2004 Dec; 44(1):116-20. PubMed ID: 15599912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.